| Efficacy, tolerability, and safety of erenumab for the preventive treatment of persistent post-traumatic headache attributed to mild traumatic brain injury: an open-label study H Ashina, A Iljazi, HM Al-Khazali, AK Eigenbrodt, EL Larsen, ... The Journal of Headache and Pain 21, 1-9, 2020 | 62 | 2020 |
| Two-hour infusion of vasoactive intestinal polypeptide induces delayed headache and extracranial vasodilation in healthy volunteers L Pellesi, MAM Al-Karagholi, BA Chaudhry, CL Lopez, J Snellman, ... Cephalalgia 40 (11), 1212-1223, 2020 | 34 | 2020 |
| Risk factors for the development of posttraumatic headache attributed to traumatic brain injury: a systematic review AM Andersen, H Ashina, A Iljazi, HM AlKhazali, B Chaudhry, M Ashina, ... Headache: The Journal of Head and Face Pain 60 (6), 1066-1075, 2020 | 32 | 2020 |
| Dizziness and vertigo during the prodromal phase and headache phase of migraine: A systematic review and meta-analysis A Iljazi, H Ashina, RB Lipton, B Chaudhry, HM Al-Khazali, JG Naples, ... Cephalalgia 40 (10), 1095-1103, 2020 | 22 | 2020 |
| CGRP-induced migraine-like headache in persistent post-traumatic headache attributed to mild traumatic brain injury H Ashina, A Iljazi, HM Al-Khazali, TP Do, AK Eigenbrodt, EL Larsen, ... The Journal of Headache and Pain 23 (1), 135, 2022 | 14 | 2022 |
| The effect of pituitary adenylate cyclase-activating peptide-38 and vasoactive intestinal peptide in cluster headache ALH Vollesen, A Snoer, B Chaudhry, AS Petersen, A Hagedorn, ... Cephalalgia 40 (13), 1474-1488, 2020 | 14 | 2020 |
| PACAP38-and VIP-induced cluster headache attacks are not associated with changes of plasma CGRP or markers of mast cell activation L Pellesi, BA Chaudhry, ALH Vollesen, AH Snoer, K Baumann, PS Skov, ... Cephalalgia 42 (8), 687-695, 2022 | 13 | 2022 |
| Plasma levels of CGRP during a 2-h infusion of VIP in healthy volunteers and patients with migraine: an exploratory study L Pellesi, MAM Al-Karagholi, R De Icco, BA Chaudhry, CL Lopez, ... Frontiers in Neurology 13, 871176, 2022 | 10 | 2022 |
| Hypersensitivity to PACAP-38 in post-traumatic headache: a randomized clinical trial HM Al-Khazali, RH Christensen, DW Dodick, BA Chaudhry, FM Amin, ... Brain 147 (4), 1312-1320, 2024 | 5 | 2024 |
| Menstrual migraine is caused by estrogen withdrawal: revisiting the evidence B Raffaelli, TP Do, BA Chaudhry, M Ashina, FM Amin, H Ashina The journal of headache and pain 24 (1), 131, 2023 | 4 | 2023 |
| Hypersensitivity to opening of ATP-sensitive potassium channels in post-traumatic headache HM Al-Khazali, RH Christensen, DW Dodick, BA Chaudhry, R Burstein, ... Cephalalgia 43 (11), 03331024231210930, 2023 | 3 | 2023 |
| Cluster headache–The worst possible pain on YouTube BA Chaudhry, TP Do, H Ashina, M Ashina, FM Amin Headache: The Journal of Head and Face Pain 62 (9), 1222-1226, 2022 | 3 | 2022 |
| Real-world efficacy and tolerability of fremanezumab in adults with chronic migraine: a 3-month, single-center, prospective, observational study CK Cullum, BA Chaudhry, TP Do, FM Amin Frontiers in Neurology 14, 1226591, 2023 | 2 | 2023 |
| Activation of ATP-sensitive potassium channels triggers migraine attacks independent of calcitonin gene-related peptide receptors: a randomized placebo-controlled trial B Raffaelli, TP Do, BA Chaudhry, FM Amin, H Ashina, J Snellman, ... Cephalalgia 44 (1), 03331024231222916, 2024 | 1 | 2024 |
| Effects of PDE-3 inhibition in persistent post-traumatic headache: evidence of cAMP-dependent signaling HM Al-Khazali, RH Christensen, BA Chaudhry, AG Melchior, M Ashina, ... The Journal of Headache and Pain 25 (1), 56, 2024 | | 2024 |
| No wearing-off effect of erenumab or fremanezumab for chronic migraine prevention: a single-center, real-world, observational study AM Florescu, LV Lannov, S Younis, CK Cullum, BA Chaudhry, TP Do, ... Cephalalgia 44 (1), 03331024231222915, 2024 | | 2024 |
| Average-steps per day as marker of treatment response in adults with chronic migraine: a cross-sectional study FT Jantzen, BA Chaudhry, I Norgaard, CK Cullum, TP Do, FM Amin CEPHALALGIA 43 (1 supp), 319-319, 2023 | | 2023 |
| Plasma levels of VIP are not elevated during PACAP-and VIP-induced cluster headache attacks: an exploratory study C Deligianni, L Pellesi, BA Chaudhry, AL Haulund Vollesen, AH Snoer, ... Frontiers in Neurology 14, 1135246, 2023 | | 2023 |
| Improved Osteoarthritis during Erenumab Treatment for Migraine: A Case Report FT Jantzen, RH Christensen, BA Chaudhry, FM Amin Case Reports in Neurology 15 (1), 95-99, 2023 | | 2023 |
| Induction of cluster headache after opening of adenosine triphosphate-sensitive potassium channels: a randomized clinical trial HM Al-Khazali, CI Deligianni, L Pellesi, MAM Al-Karagholi, H Ashina, ... Pain, 10.1097, 2022 | | 2022 |
Messoud AshinaDanish Headache Center, Department of Neurology, Rigshospitalet Glostrup, University of Copenhagen在 dadlnet.dk 的电子邮件经过验证
